Bonaca, M. ., Bhatt, D. ., Cohen, M. ., Steg, P. ., Storey, R. ., Jensen, E. ., … and, I. P.-T. 54 S. C. (2015). Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, 372(19), 1791-800. https://doi.org/10.1056/NEJMoa1500857 (Original work published 2015)

Inohara, T. ., Xian, Y. ., Liang, L. ., Matsouaka, R. ., Saver, J. ., Smith, E. ., … Fonarow, G. . (2018). Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality. JAMA. https://doi.org/10.1001/jama.2017.21917 (Original work published 2018)

Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., Ketchum, S. ., … REDUCE-IT, I. . (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)

Verma, S. ., Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., … REDUCE-IT, I. . (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)